PALATIN TECHNOLOGIES, INC. Retained Earnings
PALATIN TECHNOLOGIES, INC. (PTN) had Retained Earnings of -$463.09 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-05-13
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$463.09M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$461.66M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$454.40M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$459.07M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-03-31 | -$463.09M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | -$461.66M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | -$454.40M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$459.07M 10-Q · filed 2026-05-13 | |
| 2025-03-31 | -$456.84M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$452.03M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | -$449.59M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$441.77M 10-K · filed 2025-09-23 | |
| 2024-03-31 | -$433.52M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$425.08M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | -$421.38M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$412.03M 10-K · filed 2024-09-30 | -$415.54M 10-K · filed 2023-09-28 |
| 2023-03-31 | -$404.82M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$397.67M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | -$396.25M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$387.99M 10-K · filed 2023-09-28 | |
| 2022-03-31 | -$375.23M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$367.59M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | -$358.91M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$351.80M 10-K · filed 2022-09-22 | |
| 2021-03-31 | -$337.86M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$332.13M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | -$322.14M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$318.20M 10-K · filed 2021-09-28 | |
| 2020-03-31 | -$310.90M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$305.52M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | -$300.27M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$295.77M 10-K · filed 2020-09-25 | |
| 2019-03-31 | -$348.00M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$342.27M 10-Q · filed 2019-02-11 | |
| 2018-09-30 | -$337.23M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$332.05M 10-K · filed 2019-09-12 | |
| 2018-03-31 | -$343.85M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | -$343.11M 10-Q · filed 2018-02-12 | |
| 2017-09-30 | -$346.14M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | -$356.74M 10-K · filed 2018-09-13 | |
| 2017-03-31 | -$370.06M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$366.49M 10-Q · filed 2017-02-10 | |
| 2016-09-30 | -$356.47M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$343.41M 10-K · filed 2017-09-25 | |
| 2016-03-31 | -$330.06M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$317.36M 10-Q · filed 2016-02-12 | |
| 2015-09-30 | -$304.11M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | -$291.70M 10-K · filed 2016-09-19 | |
| 2015-03-31 | -$279.61M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | -$270.46M 10-Q · filed 2015-02-12 | |
| 2014-09-30 | -$273.24M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$274.03M 10-K · filed 2015-09-18 | |
| 2014-03-31 | -$269.71M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$268.20M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$264.59M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | -$260.11M 10-K · filed 2014-09-12 | |
| 2013-03-31 | -$255.39M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | -$251.37M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | -$249.70M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$239.24M 10-K · filed 2013-09-27 | |
| 2012-03-31 | -$233.99M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | -$227.97M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | -$225.34M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$221.99M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |